41. A novel antibody discovery platform identifies anti-influenza A broadly neutralizing antibodies from human memory B cells. Issue 5 (3rd July 2016) Authors: Xiao, Xiaodong; Chen, Yan; Varkey, Reena; Kallewaard, Nicole; Koksal, Adem C.; Zhu, Qing; Wu, Herren; Chowdhury, Partha S.; Dall'Acqua, William F. Journal: MAbs Issue: Volume 8:Issue 5(2016) Page Start: 916 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
42. A novel antibody targeting TIM-3 resulting in receptor internalization for cancer immunotherapy. (9th November 2020) Authors: Kuang, Zhihui; Li, Li; Zhang, Pan; Chen, Bingliang; Wu, Min; Ni, Haiqing; Yi, Shuai; Zou, Jia; Liu, Junjian Journal: Antibody therapeutics Issue: Volume 3:Number 4(2020) Page Start: 227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
43. A novel bicistronic gene design couples stable cell line selection with a fucose switch in a designer CHO host to produce native and afucosylated glycoform antibodies. Issue 3 (3rd April 2018) Authors: Roy, Gargi; Martin, Tom; Barnes, Arnita; Wang, Jihong; Jimenez, Rod Brian; Rice, Megan; Li, Lina; Feng, Hui; Zhang, Shu; Chaerkady, Raghothama; Wu, Herren; Marelli, Marcello; Hatton, Diane; Zhu, Jie; Bowen, Michael A. Journal: MAbs Issue: Volume 10:Issue 3(2018) Page Start: 416 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
44. A novel biparatopic hybrid antibody-ACE2 fusion that blocks SARS-CoV-2 infection: implications for therapy. Issue 1 (1st January 2020) Authors: Miao, Xiaoniu; Luo, Yi; Huang, Xi; Lee, Suki M. Y.; Yuan, Zhijun; Tang, Yongzhou; Chen, Liandi; Wang, Chao; Wu, Fan; Xu, Yifeng; Jiang, Wenchao; Gao, Wei; Song, Xuedong; Yan, Yao; Pang, Tuling; Chen, Cheng; Zou, Yuefeng; Fu, Weihui; Wan, Liping; Gilbert-Jaramillo, Javier Journal: MAbs Issue: Volume 12:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
45. A novel human monoclonal antibody specific to the A33 glycoprotein recognizes colorectal cancer and inhibits metastasis. Issue 1 (1st January 2020) Authors: Murer, Patrizia; Plüss, Louis; Neri, Dario Journal: MAbs Issue: Volume 12:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
46. A novel IgG Fc by computer-aided design enhances heavy-chain heterodimerization in bi- or trispecific antibodies. (1st August 2022) Authors: Wang, Bo; Lin, Jun; Hoag, Matthew R; Wright, Meredith; Ma, Mingjun; Cai, Wenyan; Gallolu Kankanamalage, Sachith; Liu, Yue Journal: Antibody therapeutics Issue: Volume 5:Number 3(2022) Page Start: 216 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
47. A novel IgM intranasal intervention against SARS-CoV-2. (28th August 2021) Authors: Yerabham, Antony; Ho, Mitchell Journal: Antibody therapeutics Issue: Volume 4:Number 3(2021) Page Start: 171 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
48. A perspective toward mass spectrometry-based de novo sequencing of endogenous antibodies. Issue 1 (31st December 2022) Authors: de Graaf, Sebastiaan C.; Hoek, Max; Tamara, Sem; Heck, Albert J. R. Journal: MAbs Issue: Volume 14:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
49. A Phase 1 and pharmacokinetic study evaluating daily or weekly schedules of the humanized anti-GD2 antibody hu14.18K322A in recurrent/refractory solid tumors. Issue 1 (1st January 2020) Authors: Bishop, Michael W.; Hutson, Paul R.; Hank, Jacquelyn A.; Sondel, Paul M.; Furman, Wayne L.; Meagher, Michael M.; Navid, Fariba; Santana, Victor M. Journal: MAbs Issue: Volume 12:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
50. A Phase 1 and pharmacokinetic study evaluating daily or weekly schedules of the humanized anti-GD2 antibody hu14.18K322A in recurrent/refractory solid tumors. Issue 1 (1st January 2020) Authors: Bishop, Michael W.; Hutson, Paul R.; Hank, Jacquelyn A.; Sondel, Paul M.; Furman, Wayne L.; Meagher, Michael M.; Navid, Fariba; Santana, Victor M. Journal: MAbs Issue: Volume 12:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗